Learn about AMICUS ASSIST®, get information about individualized financial support, check out the Galafold MyDay app, explore different organizations that support the Fabry community, and download printable materials.
AMICUS ASSIST is a service designed to provide product assistance and support for Galafold.* As part of the program, you’ll be assigned a dedicated case manager.
*Individuals must be prescribed Galafold for an approved indication to be eligible for support from AMICUS ASSIST®.
We are committed to helping you get access to Galafold. For example, your case manager can:
Verify and explain your insurance coverage
Identify possible sources of financial assistance
AMICUS ASSIST is dedicated to helping identify possible sources of financial assistance, including:
Co-pay assistance is only available for patients with commercial (private) prescription drug insurance. Patients are not eligible for co-pay assistance if they are enrolled in a state or federally-funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, VA, DOD, or a state prescription drug assistance program or where prohibited by law. Offer is subject to program maximum limits. Offer is only available for U.S. residents who have a valid prescription for an Amicus product. Amicus reserves the right to rescind, revoke, or amend this offer without notice.
The Patient Assistance Program provides free product to those who qualify. Contact AMICUS ASSIST for details.
Amicus makes no representation or guarantee concerning reimbursement or coverage for any service or item. Information provided through the AMICUS ASSIST program does not constitute medical advice and is not intended to be a substitute for a consultation with a licensed healthcare provider or applicable third-party payer(s). Amicus reserves the right to modify the program at any time without notice.
For all questions concerning insurance, including those on the prior-authorization process, please contact your case manager anytime Monday–Friday, 8AM–8PM ET.
Women & Fabry Forum
Sunday 4/11 3:15 Eastern Time
We all need a little help remembering things from time to time. That’s why we designed the Galafold MyDay app, your Fabry monitoring hub to help you keep track of your care and your Galafold routine.
Download today to get reminders about:
Download today to get reminders about:
Apple, the Apple logo, and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries and regions. App Store is a service mark of Apple Inc.
Google Play and the Google Play logo are trademarks of Google LLC.
Plan for future doctor appointments and help guide discussions with your healthcare providers. You can describe how Fabry is affecting you, discuss treatment, ask questions, and set future goals, among other talking points.Prepare your guide
Help determine who in your family may be at risk for Fabry disease.Build my family tree
FSIG: Fabry Support & Information GroupVisit site
NORD: National Organization for Rare DisordersVisit site
Before taking Galafold® (migalastat), tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of Galafold?
The most common side effects of Galafold include headache, stuffy or runny nose and sore throat, urinary tract infection, nausea, and fever.
These are not all the possible side effects of Galafold. Call your healthcare provider for medical advice about side effects.
What is Galafold?
Galafold is a prescription medicine used to treat adults with Fabry disease who have a certain genetic change (variant) in the galactosidase alpha gene (GLA) that is responsive (amenable) to Galafold.
It is not known if Galafold is safe and effective in children.
You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Amicus Therapeutics at 1-877-4AMICUS.
Please click here for Full Prescribing Information, including Patient Information and Instructions for Use.